Login / Signup

Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.

Yoshiya TanakaKishimoto MitsumasaKoshiro SonomotoKoichi AmanoMasayoshi HarigaiAlina OnofreiJacqueline O'BrienZachary R MargolinChristine BarrYasushi MizunoEkta AgarwalNaonobu SugiyamaHisashi Yamanaka
Published in: Rheumatology and therapy (2024)
GOV: NCT05572567.
Keyphrases
  • rheumatoid arthritis
  • disease activity
  • randomized controlled trial
  • systematic review
  • high dose
  • rheumatoid arthritis patients
  • adverse drug
  • drug induced
  • emergency department
  • systemic lupus erythematosus